Pure Global

Investigation of the Effect of Body Mass Index and Anxiety on Masseter Muscle Thickness on Ultrasonography - Trial NCT06113822

Access comprehensive clinical trial information for NCT06113822 through Pure Global AI's free database. This phase not specified trial is sponsored by Oguzhan Deveci and is currently Completed. The study focuses on Anxiety. Target enrollment is 5 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
Device Trial
NCT06113822
Completed
Device Trial
device
Trial Details
ClinicalTrials.gov โ€ข NCT06113822
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Investigation of the Effect of Body Mass Index and Anxiety on Masseter Muscle Thickness on Ultrasonography
Investigation of The Effect of Body Mass Index and Anxiety on Masseter Muscle Thickness on Ultrasonography

Study Focus

Anxiety

ultrasonography

Observational

device

Sponsor & Location

Oguzhan Deveci

Firat University

Elazฤฑg, Turkey

Timeline & Enrollment

N/A

Mar 01, 2022

Oct 30, 2023

5 participants

Primary Outcome

BMI and anxiety

Summary

The aim of this study is to determine the effect of body mass index (BMI) and anxiety on
 masseter muscle thickness by using ultrasonography.

ICD-10 Classifications

Anxiety disorder, unspecified
Other anxiety disorders
Phobic anxiety disorders
Phobic anxiety disorder, unspecified
Generalized anxiety disorder

Data Source

ClinicalTrials.gov

NCT06113822

Device Trial